Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Research and Innovation Action · Running

DORIAN GRAY Devising a personalized risk stratification and holistic management for prevention of cognitive impairment in patients with different cardiovascular phenotypes

Coordinator
Universita Degli Studi Di Brescia, Italy
Runs
1 January 2025 to 31 December 2029
Status
Running
EU funding
€10.9m
Total cost
—
Partners
26 organisations in 14 countries
Type
Research and Innovation Action
Grant agreement
101156266

What the project is doing

In the project's own words, from its summary on CORDIS.

DORIAN GRAY project investigates the link between cardiovascular disease (CVD) and Mild Cognitive Impairment (MCI) in the ageing population. Its goal is to uncover underlying mechanisms to promote healthy, independent, and active living while reducing disease burden. Aligned with Horizon Europe’s Strategic Plan on NCDs prevention, the project focuses on two core objectives: designing a multidomain intervention to delay CVD-related MCI progression and developing digital solutions to enhance its adherence.

By leveraging large datasets that include omics, brain imaging, lifestyle behaviors, and socio-economic data, the project aims to develop a trustworthy AI tool for predicting MCI. The AI tool will be upgraded into a state-of-the-art framework for modelling and simulation (digital twin), integrating real-world data collected in clinical studies from smartwatches and mobile devices. Including these digital biomarkers enable the early detection of disease and enhance precision in healthcare.

The DIGITAL TWIN will inform and update a personalized multidomain intervention using a novel avatar-based coaching exergame, which will serve dual purposes: as a cognitive enhancement tool with structured physical-cognitive tasks and as a lifestyle intervention promoting positive behaviours experienced in the virtual environment. Feasibility will be tested in a pilot randomized controlled trials involving patients with MCI and heart failure, and in an implementation study with patients having MCI and cardiovascular risk factors.

To achieve his aim DORIAN GRAY brings together a diverse team of experts, including clinicians, psychologists, sports scientists, computers engineers, AI specialists, stakeholders, entrepreneurs, and academics in ethics, law, and theoretical philosophy. Patients and citizens actively engage in shaping and guiding project decisions. DORIAN GRAY is projected to prevent up to 2 million dementia cases over 27 years, leading to a cost reduction of 485 billion.

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di BresciaBresciaItalyCoordinator
Moverim SRLBruxelles / BrusselBelgiumParticipant
Haute Ecole Specialisee De Suisse OccidentaleDelemontSwitzerlandAssociatedpartner
Infotrend Innovations Company LimitedLefkosiaCyprusParticipant
Fakultni Nemocnice U Sv Anny V BrneBrnoCzechiaParticipant
Krajska Nemocnice Liberec ASLiberecCzechiaParticipant
Univerzita Hradec KraloveHradec KraloveCzechiaParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Nurogames GmbHKolnGermanyParticipant
Universitaetsklinikum Wuerzburg - Klinikum Der Bayerischen Julius-Maximilians-UniversitatWurzburgGermanyParticipant
Idryma Technologias Kai ErevnasIrakleioGreeceParticipant
Fondation Ophtalmologique Adolphe De RothschildParis Cedex 19FranceParticipant
Societe Europeenne De CardiologieBiotFranceParticipant
I2grow Innovation to Grow SRLMilanoItalyParticipant
Lifescience Innovation Good Healthcare Technology S.c.a R.l.BresciaItalyThird party
Politecnico Di MilanoMilanoItalyParticipant
Universita Degli Studi Di Roma La SapienzaRomaItalyParticipant
Alzheimer EuropeSenningerbergLuxembourgParticipant
Universiteit MaastrichtMaastrichtNetherlandsParticipant
Institutul De Urgenta Pentru Boli Carvasculare Prof Dr Cc IliescuBucurestiRomaniaParticipant
Ropardo SRLSibiuRomaniaParticipant
Liopep ABLinköpingSwedenParticipant
The Chancellor Masters and Scholars of the University of CambridgeCambridgeUnited KingdomParticipant
The University of LiverpoolLiverpoolUnited KingdomParticipant
University Hospitals Coventry and Warwickshire National Health Service TrustCoventryUnited KingdomParticipant
Icahn School of Medicine at Mount SinaiNew YorkUnited StatesParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI